• Explore /
  • Poster
  • / Trans-intra-arterial gemcitabine versus continuation of IV gemcitabine and nab-paclitaxel following radiotherapy for locally advanced pancreatic cancer (TIGeR-PaC).

Trans-intra-arterial gemcitabine versus continuation of IV gemcitabine and nab-paclitaxel following radiotherapy for locally advanced pancreatic cancer (TIGeR-PaC).

Abstract Poster

Authors

Michael Pishvaian

Michael J. Pishvaian

Georgetown University Medical Center, Washington, DC

Michael J. Pishvaian , Karyn A. Goodman , Emmanuel E. Zervos , Peter Muscarella , Alexander Y. Kim , Mark Bloomston , Charles W. Nutting , Ken Lee Meredith , Harish Lavu , Jennifer W. Chuy , Justin Lee , Marc Ryan Matrana , Clifford Lavarias , Scott Gellert , Ramtin Agah

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Clinical Trial Registration Number

NCT03257033

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr TPS529)

DOI

10.1200/JCO.2018.36.4_suppl.TPS529

Abstract #

TPS529

Poster Bd #

Q5

Abstract Disclosures

Similar Posters

First Author: Michael J. Pishvaian

First Author: Karyn A. Goodman

First Author: Todd Anthony Aguilera

First Author: Sarah E. Hoffe